Gliadel Wafer

UPDATE 1-MGI Pharma 2006 revenue outlook below expectations  Jan 10, 2006
Reuters The company said it expects to recognize about $8.5 million in fourth-quarter 2005 sales of Gliadel Wafer, a brain cancer treatment, and $34 million for the ...

MGI PHARMA Provides Corporate Update; 2005 Aloxi(R) Injection ...  Jan 10, 2006
Genetic Engineering News, Wafer. Total sales of Gliadel Wafer were approximately $34 million (unaudited) in 2005, a 22% increase over 2004 sales. -- Oncology ...

MGI Pharma provides '06 sales guidance  Jan 10, 2006
Twin Cities Business Journal, Sales of Gliadel Wafer, a brain tumor treatment acquired in MGI Pharma's purchase of Guilford Pharmaceuticals in October, rose 22 percent to $34 million in 2005 ...

Neopharm stock jumps on brain cancer study  Dec 27, 2005
United Press International ...will compare overall survival, drug safety and quality of life of patients receiving Neopharm's drug with patients receiving MGI Pharma's Gliadel Wafer.

Neopharm Study Can Continue  Dec 27, 2005
TheStreet.com ...after notification of 215 deaths, to demonstrate superiority (p less than or equal to 0.048) of long-term survival of cintredekin besudotox over Gliadel wafer. ...

NeoPharm brain-cancer trial backed; shares soar  Dec 27, 2005
Reuters ...survival, drug safety and quality of life of patients receiving IL13 with patients receiving MGI Pharma Inc.'s (MOGN.O: Quote, Profile, Research) Gliadel Wafer ...

NeoPharm brain-cancer trial backed  Dec 27, 2005
San Diego Union Tribune, ...is designed to compare overall survival, drug safety and quality of life of patients receiving IL13 with patients receiving MGI Pharma Inc.'s Gliadel Wafer. ...

Neopharm clears a key hurdle  Dec 28, 2005
Chicago Tribune, Using the current existing treatment known as Gliadel Wafer, median survival is 28 weeks, which means Neopharm's IL-13 has to improve median survival to 42 ...

Dacogen(TM) (Decitabine) Injection Complete Response Accepted for ...  Dec 15, 2005
Yahoo! News (press release) MGI PHARMA markets Aloxi® (palonosetron hydrochloride) injection and Gliadel® Wafer (polifeprosan 20 with carmustine implant) in the United States. ...


Home Copyright phasechange.org 2006.
All Rights Reserved.
Google
 
Web rxreview.org